Mohamad, Al-shaima .

HRN: 12-22-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
OXACILLIN 500MG (VIAL)
07/30/2026
08/05/2026
IV
1gm
Q6
Dermatitis With Superimposed Bacterial Infection
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: